OPKO Health Price to Free Cash Flow Ratio 2012-2025 | OPK
Historical price to free cash flow ratio values for OPKO Health (OPK) since 2012.
| OPKO Health Price to Free Cash Flow Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM FCF per Share | Price to FCF Ratio |
| 2026-03-05 | 1.17 | 0.00 | |
| 2025-09-30 | 1.55 | $-0.35 | 0.00 |
| 2025-06-30 | 1.32 | $-0.35 | 0.00 |
| 2025-03-31 | 1.66 | $-0.30 | 0.00 |
| 2024-12-31 | 1.47 | $-0.30 | 0.00 |
| 2024-09-30 | 1.49 | $-0.21 | 0.00 |
| 2024-06-30 | 1.25 | $-0.12 | 0.00 |
| 2024-03-31 | 1.20 | $-0.08 | 0.00 |
| 2023-12-31 | 1.51 | $-0.06 | 0.00 |
| 2023-09-30 | 1.60 | $-0.06 | 0.00 |
| 2023-06-30 | 2.17 | $-0.15 | 0.00 |
| 2023-03-31 | 1.46 | $-0.16 | 0.00 |
| 2022-12-31 | 1.25 | $-0.16 | 0.00 |
| 2022-09-30 | 1.89 | $-0.13 | 0.00 |
| 2022-06-30 | 2.53 | $0.07 | 38.80 |
| 2022-03-31 | 3.44 | $0.05 | 72.27 |
| 2021-12-31 | 4.81 | $0.11 | 43.18 |
| 2021-09-30 | 3.65 | $0.17 | 21.15 |
| 2021-06-30 | 4.05 | $0.11 | 35.28 |
| 2021-03-31 | 4.29 | $0.11 | 38.24 |
| 2020-12-31 | 3.95 | $0.01 | 0.00 |
| 2020-09-30 | 3.69 | $-0.11 | 0.00 |
| 2020-06-30 | 3.41 | $-0.24 | 0.00 |
| 2020-03-31 | 1.34 | $-0.30 | 0.00 |
| 2019-12-31 | 1.47 | $-0.31 | 0.00 |
| 2019-09-30 | 2.09 | $-0.30 | 0.00 |
| 2019-06-30 | 2.44 | $-0.31 | 0.00 |
| 2019-03-31 | 2.61 | $-0.26 | 0.00 |
| 2018-12-31 | 3.01 | $-0.24 | 0.00 |
| 2018-09-30 | 3.46 | $-0.19 | 0.00 |
| 2018-06-30 | 4.70 | $-0.22 | 0.00 |
| 2018-03-31 | 3.17 | $-0.24 | 0.00 |
| 2017-12-31 | 4.90 | $-0.23 | 0.00 |
| 2017-09-30 | 6.86 | $-0.17 | 0.00 |
| 2017-06-30 | 6.58 | $-0.14 | 0.00 |
| 2017-03-31 | 8.00 | $-0.01 | 0.00 |
| 2016-12-31 | 9.30 | $0.03 | 347.01 |
| 2016-09-30 | 10.59 | $-0.04 | 0.00 |
| 2016-06-30 | 9.34 | $-0.09 | 0.00 |
| 2016-03-31 | 10.39 | $-0.26 | 0.00 |
| 2015-12-31 | 10.05 | $0.31 | 32.03 |
| 2015-09-30 | 8.41 | $0.26 | 32.11 |
| 2015-06-30 | 16.08 | $0.32 | 49.49 |
| 2015-03-31 | 14.17 | $0.37 | 38.78 |
| 2014-12-31 | 9.99 | $-0.23 | 0.00 |
| 2014-09-30 | 8.51 | $-0.24 | 0.00 |
| 2014-06-30 | 8.84 | $-0.25 | 0.00 |
| 2014-03-31 | 9.32 | $-0.17 | 0.00 |
| 2013-12-31 | 8.44 | $-0.17 | 0.00 |
| 2013-09-30 | 8.81 | $-0.11 | 0.00 |
| 2013-06-30 | 7.10 | $-0.06 | 0.00 |
| 2013-03-31 | 7.63 | $-0.10 | 0.00 |
| 2012-12-31 | 4.81 | $-0.09 | 0.00 |
| 2012-09-30 | 4.18 | $-0.10 | 0.00 |
| 2012-06-30 | 4.60 | $-0.10 | 0.00 |
| 2012-03-31 | 4.73 | $-0.09 | 0.00 |
| 2011-12-31 | 4.90 | $-0.07 | 0.00 |
| 2011-09-30 | 4.33 | $-0.05 | 0.00 |
| 2011-06-30 | 3.69 | $-0.06 | 0.00 |
| 2011-03-31 | 3.73 | $-0.08 | 0.00 |
| 2010-12-31 | 3.67 | $-0.08 | 0.00 |
| 2010-09-30 | 2.24 | $-0.09 | 0.00 |
| 2010-06-30 | 2.26 | $-0.08 | 0.00 |
| 2010-03-31 | 1.98 | $-0.07 | 0.00 |
| 2009-12-31 | 1.83 | $-0.10 | 0.00 |
| 2009-09-30 | 2.28 | $-0.12 | 0.00 |
| 2009-06-30 | 1.77 | $-0.14 | 0.00 |
| 2009-03-31 | 0.98 | $-0.16 | 0.00 |
| 2008-12-31 | 1.62 | $-0.16 | 0.00 |
| 2008-09-30 | 1.75 | $-0.20 | 0.00 |
| 2008-06-30 | 1.52 | $-0.17 | 0.00 |
| 2008-03-31 | 2.06 | $-0.16 | 0.00 |
| 2007-12-31 | 2.85 | $-0.14 | 0.00 |
| 2007-09-30 | 4.04 | $0.16 | 24.54 |
| 2007-06-30 | 3.65 | $101.04 | 0.04 |
| 2007-03-31 | 3.71 | $-0.02 | 0.00 |
| 2006-12-31 | 0.85 | $-0.01 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.944B | $0.713B |
| OPKO Health, Inc engages in the diagnostics and pharmaceuticals business in the United States, Ireland, Chile, Spain, Israel and Mexico. The Diagnostics segment operates Bio-Reference Laboratories, a clinical facility that offers testing services in the detection, diagnosis, evaluation, monitoring and treatment of diseases. The company's pharmaceutical business features Rayaldee, an FDA-approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency and VARUBI for chemotherapy induced nausea and vomiting. OPKO Health has a development and commercial supply pharmaceutical unit in Ireland along with a global supply chain operation and holding wing. The company also owns specialty active pharmaceutical ingredients (APIs) manufacturer in Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $189.665B | 22.07 |
| Intuitive Surgical (ISRG) | United States | $172.536B | 66.55 |
| IDEXX Laboratories (IDXX) | United States | $50.254B | 48.15 |
| Edwards Lifesciences (EW) | United States | $44.027B | 29.64 |
| Alcon (ALC) | Switzerland | $39.174B | 26.40 |
| IQVIA Holdings (IQV) | United States | $28.430B | 15.36 |
| Mettler-Toledo (MTD) | United States | $27.662B | 31.81 |
| DexCom (DXCM) | United States | $26.948B | 33.50 |
| STERIS (STE) | Ireland | $24.357B | 24.64 |
| Waters (WAT) | United States | $19.256B | 24.63 |
| Coloplast (CLPBY) | Denmark | $17.511B | 26.79 |
| Hologic (HOLX) | United States | $16.752B | 17.53 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.334B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $14.168B | 11.75 |
| Penumbra (PEN) | United States | $13.288B | 93.47 |
| Globus Medical (GMED) | United States | $11.790B | 24.74 |
| SARTORIUS (SSSGY) | Germany | $7.976B | 46.32 |
| Masimo (MASI) | United States | $6.991B | 22.40 |
| Glaukos (GKOS) | United States | $6.287B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $5.363B | 17.75 |
| Teleflex (TFX) | United States | $4.585B | 7.31 |
| TransMedics (TMDX) | United States | $4.437B | 52.57 |
| LivaNova (LIVN) | United Kingdom | $3.593B | 19.41 |
| Integer Holdings (ITGR) | United States | $3.011B | 14.13 |
| Veracyte (VCYT) | United States | $2.828B | 32.22 |
| Elekta AB (EKTAY) | Sweden | $2.266B | 21.19 |
| Alphatec Holdings (ATEC) | United States | $1.985B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $1.975B | 21.79 |
| UFP Technologies (UFPT) | United States | $1.896B | 25.03 |
| Artivion (AORT) | United States | $1.734B | 58.10 |
| Pulse Biosciences (PLSE) | United States | $1.559B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $1.553B | 0.00 |
| AxoGen (AXGN) | United States | $1.533B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.285B | 0.00 |
| IRadimed (IRMD) | United States | $1.270B | 57.03 |
| Integra LifeSciences Holdings (IART) | United States | $0.882B | 4.78 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.692B | 13.80 |
| SiBone (SIBN) | United States | $0.665B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.614B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.612B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.591B | 34.35 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.530B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.516B | 0.00 |
| NeuroPace (NPCE) | United States | $0.501B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.500B | 13.03 |
| AngioDynamics (ANGO) | United States | $0.452B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.424B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.385B | 0.00 |
| RxSight (RXST) | United States | $0.331B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.329B | 54.76 |
| Semler Scientific (SMLR) | United States | $0.311B | 2.32 |
| Sight Sciences (SGHT) | United States | $0.283B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.281B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.235B | 0.00 |
| 908 Devices (MASS) | United States | $0.235B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.183B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.175B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.173B | 0.00 |
| Inogen (INGN) | United States | $0.156B | 0.00 |
| Nano-X Imaging (NNOX) | Israel | $0.149B | 0.00 |
| LENSAR (LNSR) | United States | $0.146B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.146B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.132B | 0.00 |
| CVRx (CVRX) | United States | $0.130B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.119B | 0.00 |
| Hyperfine (HYPR) | United States | $0.108B | 0.00 |
| Neuronetics (STIM) | United States | $0.097B | 0.00 |
| Solana (HSDT) | United States | $0.091B | 0.00 |
| DarioHealth (DRIO) | United States | $0.079B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.078B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| Positron (POSC) | United States | $0.067B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.067B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.063B | 0.00 |
| Accuray (ARAY) | United States | $0.062B | 0.00 |
| Spectral AI (MDAI) | United States | $0.048B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.036B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.026B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.021B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.020B | 0.00 | |
| Envoy Medical (COCH) | United States | $0.017B | 0.00 |
| Check-Cap (MBAI) | Israel | $0.013B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.011B | 0.00 |
| NexGel (NXGL) | United States | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.006B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ENvue Medical (FEED) | United States | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |